About Nanopore
Nanopore is a company based in Oxford (United Kingdom) founded in 2005 by Hagan Bayley and Gordon Sanghera. Nanopore has raised $1.3 billion across 24 funding rounds from investors including Amgen, Illumina and Nikon. The company has 1,480 employees as of December 31, 2024. Nanopore operates in a competitive market with competitors including PacBio, Omniome, Complete Genomics, GenapSys and QuantuMDx, among others.
- Headquarter Oxford, United Kingdom
- Employees 1480 as on 31 Dec, 2024
- Founders Hagan Bayley, Gordon Sanghera
- Stage Public
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Oxford Nanopore Technologies Plc
-
Annual Revenue
$229.52 M (USD)7.97as on Dec 31, 2024
-
Net Profit
-$183.17 M (USD)5.38as on Dec 31, 2024
-
EBITDA
-$137.26 M (USD)14.66as on Dec 31, 2024
-
Total Equity Funding
$1.3 B (USD)
in 24 rounds
-
Latest Funding Round
$64.21 M (USD), Post-IPO
Aug 01, 2024
-
Investors
Amgen
& 22 more
-
Employee Count
1480
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Nanopore
Nanopore is a publicly listed company on the LSE with ticker symbol ONT in UK, operating in the Electronic technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Nanopore
Unlock access to complete
Unlock access to complete
Sales and Marketing
37 people
Leadership Team
33 people
Software Development Team
31 people
Product Management Team
26 people
Human Resources and Administration
13 people
Finance and Accounting
9 people
Senior Team
6 people
Creative and Marketing Team
4 people
Unlock access to complete
Funding Insights of Nanopore
Nanopore has successfully raised a total of $1.3B across 24 strategic funding rounds. The most recent funding activity was a Post-IPO round of $64.21 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nanopore
Nanopore has secured backing from 23 investors, including venture fund and institutional investors. Prominent investors backing the company include Amgen, Illumina and Nikon.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital fund focused on the healthcare sector
|
Locked | Locked | Locked | |
|
An investment platform is provided for diverse sectors and geographies.
|
Locked | Locked | Locked | |
|
Sovereign wealth is managed and private equity investments are facilitated.
|
Locked | Locked | Locked |
Investor details for Nanopore
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nanopore
Investment portfolio details for Nanopore
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nanopore
Detailed financials for Nanopore
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nanopore Comparisons
Peer comparison for Nanopore
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nanopore
Nanopore operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PacBio, Omniome, Complete Genomics, GenapSys and QuantuMDx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
DNA sequencing platform for human genome analysis is developed.
|
|
| Locked | Locked | Locked |
Provider of DNA sequencing technologies for applied genomic testing and medical sequencing
|
|
| Locked | Locked | Locked |
Handheld diagnostic and sequencing devices are developed for personalized healthcare.
|
Detailed competitors of Nanopore
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nanopore
Complete news archive for Nanopore
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nanopore
Nanopore was founded in 2005.
Nanopore is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Gordon Sanghera is the current CEO of Nanopore. They have also founded this company.
Nanopore is a funded company, having raised a total of $1.3B across 24 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Nanopore is 1,480.
Annual revenue of Nanopore is $229.52M as on Dec 31, 2024.
Developer of nanopore-based electronic systems for the analysis of single molecules. It produces nanopore-based systems that use DNA sequencing and proprietary electronics to detect and identify the bases in DNA. It also manufactures the necessary reagents and instruments for library preparation, including a microfluidic automated library preparation system. It also develops bespoke software for real-time analysis of data produced by the sequencing systems.
Nanopore's top competitors include PacBio, QuantuMDx and Complete Genomics.
Yes, Nanopore is publicly traded on LSE under the ticker symbol ONT.
The ticker symbol of Nanopore is ONT on LSE.